IL6 and ovarian carcinoma: Similarly, autocrine and paracrine signaling pathways stimulated by Interleukin-6, encoded by IL6, were shown to be associated with cancer cell proliferation, migration, stemness, and therapy resistance in ovarian cancer [40,41].